HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

VIEVVQRACRAILHI gp160(829-843) mouse epitope
 IEVVQRACRAILHIPRRI gp160(830-847) human epitope
 IEVVQRACRAILHIPRkI gp160(830-847) observed variant
 IEiVQRACRAILHIPRRI gp160(830-847) observed variant
 IEVVQRACRAIcHIPRRI gp160(830-847) observed variant
 IEVVQRACRAIrHIPRRI gp160(830-847) observed variant
 IEVVQRACRAILHIPRRI gp160(830-847) human epitope
 IEVVQRACRAIfHIPRRI gp160(830-847) observed variant
 IEiVQRACRAILHIPRRI gp160(830-847) observed variant
 IEVVQRACRAILHIPRkI gp160(830-847) observed variant
 IEVVQRACRAIcHIPRRI gp160(830-847) observed variant
 IEVVQRACRAIrHIPRRI gp160(830-847) observed variant
 IEVVQRACRAILHIPRRIRQ gp160(830-849) human epitope
 IEVVQGAYRAIIRHIPRRIRQGLERI gp160(830-854) human epitope
    LQRAGRAILHIPTRI gp160(833-847) human epitope
      RAYRAILHI gp160(835-843) B51 human epitope
      RtfRAILHI gp160(835-843) observed variant
      RiYRAILHx gp160(835-843) observed variant
      RAYRAILHI gp160(835-843) B*51:01 human epitope
      RACRAILHI gp160(835-843) human epitope
       IGRAILHIPR gp160(836-845) B*27:05 human epitope
        CRAILHIPR gp160(837-845) B*27:02 human epitope
        CRAILHIPR gp160(837-845) B*27:05 human epitope
        YRAIRHIPRRIRQGLERILL gp160(837-856) A30, B35 human epitope
        YRAIRHIPRRIRQGLERILL gp160(837-856) B8 human epitope
        YRAIRHIPRRIRQGLERILL gp160(837-856) human epitope
        CRAILHIPRRIRQGLERALL gp160(837-856) human epitope
        RAILHIPRRIRQGLERsL gp160(837-856) observed variant
        RAILHIPtRIRQGLERcL gp160(837-856) observed variant
        YRAIRHIPRRIRQGLERILL gp160(837-856) human epitope
         RAIYSIPRR gp160(838-846) human epitope
         RAILHIPRRIRQGLERSL gp160(838-855) human epitope
         RAILHIPtRIRQGLERcL gp160(838-855) observed variant
         CRAILHIPRRIRQGLERALL gp160(838-855) observed variant
         RAVLNIPTRIRQGLERAL gp160(838-855) human epitope
         RAVLNvPTRIRQGLERAL gp160(838-855) observed variant
         RAILHIPRRIRQGLERAL gp160(838-855) human epitope
         RAILHIPTRIRQGLERCL gp160(838-855) human epitope
         CRAILHIPrRIRQGLERaLL gp160(838-855) observed variant
         RAILHIPrRIRQGLERsL gp160(838-855) observed variant
           ILHIPRRIRQGLERA gp160(840-854) human epitope
            RNIPIRIRQ gp160(841-849) human epitope
            LNIPRRIRQGLERAL gp160(841-855) B*07:02 human epitope
            LHIPTRIRQGLERAL gp160(841-855) human epitope
             HIPRRIRQGLERALL gp160(842-856) human epitope
             HIPRRIRQGLERALL gp160(842-856) human epitope
              IPRRIRQGL gp160(843-851) A*02:01 human epitope
              IPRRIRQGL gp160(843-851) A*29 human epitope
              IPRRIRQGL gp160(843-851) B*07 human, transgenic mouse epitope
              IPRRIRQGf gp160(843-851) susceptible form
              IPRRRIRQGL gp160(843-851) B*07 human epitope
              IPRRIRQGL gp160(843-851) B*07 human epitope
              IPRRIRQGF gp160(843-851) B*07 human epitope
              IPRRIRQGL gp160(843-851) B*07 human epitope
              IPRRIRQGL gp160(843-851) B*07 human epitope
              IPRRIRQGL gp160(843-851) B*07 human epitope
              IPRRIRQGL gp160(843-851) B*07:02 human epitope
              IPRRIRQGL gp160(843-851) B*07:02 human epitope
              IPRRIRQGL gp160(843-851) B*07:02 human epitope
              IPRRIRQGf gp160(843-851) subtype-specific susceptible form
              IPRRIRQGL gp160(843-851) B*07:02 human epitope
              IPRRIRQGL gp160(843-851) B*07:02 human epitope
              IPtRIRQGL gp160(843-851) literature escape
              IPRRIRQGL gp160(843-851) B*41 human epitope
              IPRRIRQGF gp160(843-851) B*42 human epitope
              lPRRIRQGF gp160(843-851) observed variant
              IPRRvRQGF gp160(843-851) observed variant
              IPRRlRQGF gp160(843-851) observed variant
              IPRRfRQGF gp160(843-851) observed variant
              IPtRIRQGF gp160(843-851) observed variant
              IPRRIRQGF gp160(843-851) B*42:01 human epitope
              IPRRIRQGL gp160(843-851) B*42:01 human epitope
              IPRRIRQGF gp160(843-851) B*42:01 human epitope
              IPRRIRQGF gp160(843-851) B*42:01 human epitope
              vPRRIRQGF gp160(843-851) escape documented in this paper; observed variant
              IPtRIRQGF gp160(843-851) escape documented in this paper; observed variant
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQdL gp160(843-851) non-susceptible form
              IPtRIRQGL gp160(843-851) diminished response
              IPRRlRQGL gp160(843-851) diminished response
              IPtRIRQGf gp160(843-851) non-susceptible form
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGf gp160(843-851) subtype-specific susceptible form
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGf gp160(843-851) calculated diminished HLA binding; observed variant
              IPtRIRQGL gp160(843-851) calculated diminished HLA binding; observed variant
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGF gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              vPRRIRQGL gp160(843-851) observed variant
              IPgRIRQGL gp160(843-851) observed variant
              IPRRkRQGL gp160(843-851) observed variant
              IPRRIRQGf gp160(843-851) observed variant
              IPRRIRQGL gp160(843-851) B7 epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B7 human epitope
              IPRRIRQGL gp160(843-851) B*81 human epitope
              IPRRIRQGL gp160(843-851) C*05 human epitope
              IPRRIRQGF gp160(843-851) human epitope
              IPTRIRQGL gp160(843-851) human epitope
              IPrRIRQGL gp160(843-851) observed variant
              IPRRIRQGL gp160(843-851) human epitope
              IPRRIRQGf gp160(843-851) subtype-specific susceptible form
              IPRRIRQGA gp160(843-851) human epitope
              IPRRIRQGL gp160(843-851) human epitope
              IPRRIRQGL gp160(843-851) human epitope
              IPRRIRQGA gp160(843-851) human epitope
              IPRRIRQGF gp160(843-851) human epitope
              IPRRIRQGL gp160(843-851) human epitope
              IPRRIRQGF gp160(843-851) human epitope
              IPRRIRQGL gp160(843-851) human epitope
              IPRRIRQGf gp160(843-851) subtype-specific susceptible form
              IvRRIRQGL gp160(843-851) subtype-specific susceptible form
              IPRRIRQGLA gp160(843-852) B*07:02 human epitope
                RRIRQGLERILL gp160(845-856) A30, B8 human epitope
                RRIRQGLERILL gp160(845-856) B7, B8 human epitope
                RRIRQGLERILL gp160(845-856) human epitope
                 RIRQGLERA gp160(846-854) A*02:05 human epitope
                 RIRQGfERA gp160(846-854) observed variant
                 RIRQGLEaA gp160(846-854) observed variant
                 RIRQGfEaA gp160(846-854) observed variant
                 RIRQGLfRA gp160(846-854) observed variant
                 RIRQGLERA gp160(846-854) A*02:05 human epitope
                 RIRQGLERA gp160(846-854) A*02:05 human epitope
                 RIRQGLERA gp160(846-854) A*02:05 human epitope
                 RIRQGLERA gp160(846-854) A2 human epitope
                 RIRQGLERA gp160(846-854) A2 human epitope
                 RIRQGLERA gp160(846-854) human epitope
                 RIRQGLERALL gp160(846-856) human epitope
                  IRQGLERAL gp160(847-855) B*27:02 human epitope
                  IRQGLERAL gp160(847-855) B*27:05 human epitope
                   RQGFERALL gp160(848-856) A*02 human epitope
                   RQGLERALL gp160(848-856) B*07 human epitope
                   RQGLERALL gp160(848-856) B*08 epitope
                   RQGLERALL gp160(848-856) B*08 human epitope
                   RQGLERALL gp160(848-856) B*08 human epitope
                   RQGLERALL gp160(848-856) B*08, B8 human epitope
                   RQGLERALL gp160(848-856) B*40 human epitope
                   RQGLERALL gp160(848-856) B*45 human epitope
                   RQGLERALL gp160(848-856) B8 epitope
                   RQGLERALL gp160(848-856) B8 human epitope
                   RQGLERvLL gp160(848-856) inferred escape
                   RQGLERAfL gp160(848-856) inferred escape
                   RQGLERALL gp160(848-856) C*06 human epitope
                   RQGLERALL gp160(848-856) human epitope
                   RQGfERALL gp160(848-856) susceptible form
                   RQGLERALL gp160(848-856) human epitope
                   RQGFERALL gp160(848-856) human epitope
                   RQGlERALL gp160(848-856) susceptible form
                    QGLERALL gp160(849-856) B8 human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health